CNS pipeline · person
Jude Onyia, PhD
Chief Scientific Officer of Neurocrine Biosciences since November 2021, leading the drug discovery and non-clinical development teams. A scientist with more than 25 years of pharmaceutical industry experience, he is the former Vice President of Biotechnology Discovery Research at Eli Lilly and Company.
- 1 company
Courtesy Neurocrine Biosciences
Current roles
- Neurocrine Biosciences, Inc.Chief Scientific Officer · Executive
Appears with
People sharing a company with Jude.
- Andrew Ratz · Neurocrine Biosciences, Inc.
- Christine A. Poon · Neurocrine Biosciences, Inc.
- Darin M. Lippoldt · Neurocrine Biosciences, Inc.
- David W. Boyer · Neurocrine Biosciences, Inc.
- Eric Benevich · Neurocrine Biosciences, Inc.
- Gary A. Lyons · Neurocrine Biosciences, Inc.
- George J. Morrow · Neurocrine Biosciences, Inc.
- Ingrid Delaet · Neurocrine Biosciences, Inc.
- Johanna Mercier · Neurocrine Biosciences, Inc.
- Julie S. Cooke · Neurocrine Biosciences, Inc.
- Kevin C. Gorman · Neurocrine Biosciences, Inc.
- Kyle W. Gano · Neurocrine Biosciences, Inc.
- Leslie V. Norwalk · Neurocrine Biosciences, Inc.
- Matthew C. Abernethy · Neurocrine Biosciences, Inc.
- Richard F. Pops · Neurocrine Biosciences, Inc.
- Sanjay Keswani · Neurocrine Biosciences, Inc.
- Shalini Sharp · Neurocrine Biosciences, Inc.
- Stephen A. Sherwin · Neurocrine Biosciences, Inc.
- William H. Rastetter · Neurocrine Biosciences, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.